tiprankstipranks
Trending News
More News >
MiNK Therapeutics (INKT)
NASDAQ:INKT
US Market
Advertisement

MiNK Therapeutics (INKT) Income Statement

Compare
235 Followers

MiNK Therapeutics Income Statement

Last quarter (Q2 2025), MiNK Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, MiNK Therapeutics's net income was $-4.24M. See MiNK Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 2.70B$ 0.00$ 0.00
Gross Profit
$ -215.44K$ -204.62K$ -28.24B$ -77.96K$ -55.06K
Operating Expenses
$ 10.43M$ 22.72M$ 30.95M$ 28.36M$ 10.74M
Depreciation and Amortization
$ 215.44K$ 204.62K$ 121.75K$ 77.96K$ 55.06K
EBITDA
$ -10.57M$ -22.25M$ -30.83M$ -27.70M$ -13.74M
Operating Income
$ -10.65M$ -22.92M$ -30.95M$ -28.36M$ -14.64M
Other Income/Expenses
$ -134.56K$ 463.25K$ 2.96M$ -1.85M$ -1.60M
Pretax Income
$ -10.78M$ -22.46M$ -27.99M$ -30.21M$ -16.24M
Net Income
$ -10.78M$ -22.46M$ -27.99M$ -30.21M$ -16.24M
Per Share Metrics
Basic EPS
$ -2.90$ -6.54$ -8.31$ -9.03$ -4.91
Diluted EPS
$ -2.80$ -6.54$ -8.31$ -9.03$ -4.91
Weighted Average Shares Outstanding
3.74M 3.44M 3.37M 3.35M 3.31M
Weighted Average Shares Outstanding (Diluted)
3.86M 3.44M 3.37M 3.35M 3.31M
Currency in USD

MiNK Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis